We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma.
Vitolo, U., Chiappella, A., Angelucci, E., Rossi, G., Liberati, A., Cabras, M., et al. (2009). Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: A phase II multicenter study. HAEMATOLOGICA, 94(9), 1250-1258 [10.3324/haematol.2009.007005].
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: A phase II multicenter study
POGLIANI, ENRICO MARIA;
2009
Abstract
We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
5347-Article Text-24196-1-10-20200722.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
233.02 kB
Formato
Adobe PDF
|
233.02 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
